Familial Clustering of Nonalcoholic Fatty Liver Disease in Family Members of Nonalcoholic Steatohepatitis Cirrhotic Patients

Background and Aim: Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disorder with combination of environmental, genetic and metabolic factors that play role in the progression of disease. This study is aimed to explore the familial clustering of NAFLD among the family members of NASH cirrhotic patients and the association of insulin resistance, metabolic syndrome and genetic polymorphism with the familial clustering. Methods: This cross-sectional observational study included 50 NASH cirrhosis patient and 81 1st degree relatives. Family members were screened for fatty liver by ultrasonogram. Insulin resistance, metabolic syndrome, PNPLA3 and staging of liver stiffness by fibroscan were done. Results: Among 81 family members 47 (58.02%) were found having fatty liver. Of these 14(17.28%) had significant fibrosis. PNPLA3 polymorphism was higher (80.85%) in fatty liver group than (55.9%) without fatty liver groups. Sons (57.89%) and daughters (51.6%) were affected by fatty liver equally. Multivariate logistic regression analysis revealed that a subject with TG>150 mg/dl had 6.159 times increase in odds having NAFLD. A subject with PNPLA3 polymorphism had 3.33 times increase in odds having NAFLD. A subject with HOMA-IR >1.6 had 4.375 times increase in odds having NAFLD. Conclusion: This study indicates that there is a strong familial clustering of NAFLD along with significant fibrosis among the family members of NASH cirrhosis patients. This findings warrants screening for NAFLD among the family members of NASH cirrhosis patients especially with PNPLA3 polymorphism.

Callus extract of Ipomoea mauritiana show analgesic and antihyperglycemic activity in Swiss albino mice.

Callus can be a viable alternative to obtain important phytochemicals and analyze crude extract for pharmacological activities rather than going the cumbersome way of collecting and destroying possibly endangered plants. In this study, callus was produced using nodal explant of Ipomoea mauritiana, and methanol extract of dried and powdered callus was evaluated for its analgesic and antihyperglycemic potential. The extract, when administered to Swiss albino mice at doses of 50, 100, 200 and 400 mg per kg significantly reduced the number of writhings in mice produced by intraperitoneal administration of acetic acid by 23.3, 33.3, 43.3, and 53.3%, respectively. A standard analgesic drug, aspirin, at doses of 200 and 400 mg per kg, reduced the number of writhings by 40.0 and 46.7%, respectively. In oral glucose tolerance tests conducted with glucose-loaded mice, the extract at doses of 50, 100, 200 and 400 mg per kg significantly reduced blood glucose levels by 35.1, 42.5, 53.6, and 58.8%. In comparison, a standard antihyperglycemic drug, glibenclamide, at a dose of 10 mg per kg reduced blood glucose levels by 60.7%. Our study indicates that methanol extract of callus of I. mauritiana can be used to alleviate pain and high blood sugar levels.

Antioxidant, antimicrobial, toxicity and analgesic properties of ethanol extract of Solena amplexicaulis root

BACKGROUND: This study was subjected to investigate different pharmacological properties of ethanol extract ofSolena amplexicaulis root. RESULTS: The extract contains flavonoid, alkaloid, saponin and steroid compounds. The extract exhibited excellent antioxidant activity in DPPH radical scavenging activity. The extract also showed potent activity in brine shrimp lethality bioassay. The LC50 value was found to 44.677 µg/ml. The extract showed better anti-bacterial activity against gram-negative bacteria. In antifungal assay, the maximum 79.31% of anti-mycotic activity was observed against Aspergillus ochraceus while minimum 44.2% against Rhizopus oryzae. MIC value ranged between 1500 - 3000 µg/ml. The extract was found moderately toxic with a 24-hr LD50 value of 81.47 mg/kg in Swiss albino mice. The degree of inhibition by the ethanolic extract of the root was found less than that of standard analgesic drug diclofenac sodium. The extract also showed moderate anti-inflammatory and antinociceptive activity and anti-diabetic property. Reducing power of the extract was comparable with standard ascorbic acid. Moderate in vitro thrombolytic activity, lipid peroxidation inhibition property, metal chelating ability and stress-protective activity was also observed. CONCLUSION: Ethanol extract of Solena amplexicaulis root can be valuable for treatment of different diseases.

Evaluation of antioxidant, antibacterial, antifungal and cytotoxic effects of Clausena suffruticosa ethanolic root extract.

Clausena suffruticosa (Family: Rutaceae) root ethanolic extract was subjected to analyze for its antioxidant effect by DPPH free radical scavenging method, antibacterial & antifungal effect by disc diffusion technique and cytotoxic effect by brine shrimp lethality test. The extract showed very significant antioxidant activity with the LC50 value of 3.28μg/ml. In antibacterial screening, moderate zone of inhibition (7.5-9.0mm in diameter) was observed against gram positive Bacillus subtilis, Bacillus cereus, Streptococcus aureus, Bacillus polymyxa & Bacillus megaterium and promising zone of inhibition (10.0-13.0mm in diameter) against gram negative Salmonella typhi, Shigella flexneri,, Proteus sp. & Escherichia coli. Klebsiella sp. and Shigella sonnei did not show sensitivity. The MIC values against these bacteria were ranged from 3,000 to 4,500μg/ml. Root extract showed significant zone of inhibition against Aspergillus ustus, Aspergillus niger and Aspergillus ochraceus in antifungal assay. In the cytotoxicity assay, LD50 and Chi-square value of the ethanolic extract against brine shrimp nauplii were 546.94μg/ml and 1.9932 demonstrating potent cytotoxic effect of the extract.

A comparative study of thyroid hormone levels in diabetic and non-diabetic patients.

Diabetic patients have a higher prevalence of thyroid disorders than the general population, this may influence diabetic management. In this study, we investigated thyroid hormone levels in uncontrolled diabetic patients. This comparative study was conducted at the Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM). Fifty-two diabetic patients were consecutively selected from diabetic patients attending the out-patient department of BIRDEM. Fifty control subjects were selected from non-diabetic patients who attended the out-patient department of BIRDEM for routine check-ups as advised by their attending physicians. The subjects in both groups were above 30 years of age. The concentration of thyroid stimulating hormone (TSH), free triiodothyronine (FT3) and thyroxine (FT4) were evaluated using a Microparticle Enzyme Immunoassay (MEIA) procedure. Patients with type 2 diabetes had significantly lower serum FT3 levels (p = 0.000) compared to the control groups. There were no significant differences observed in serum FT4 (p = 0.339) and TSH (p = 0.216) levels between the control and study subjects. All the diabetic patients had high fasting blood glucose levels (12.15 +/- 2.12). We conclude that FT3 levels were altered in these study patients with uncontrolled diabetes.